Financhill
Back

Larimar Therapeutics Quote, Financials, Valuation and Earnings

Larimar Therapeutics Price Quote

$7.58
-0.37 (-4.59%)
(Updated: November 14, 2024 at 5:20 PM ET)

Larimar Therapeutics Key Stats

Sell
47
Larimar Therapeutics (LRMR) is a Sell

Day range:
$7.76 - $9.10
52-week range:
$2.40 - $13.68
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.91%

Volume:
943.8K
Avg. volume:
717.1K
1-year change:
232.43%
Market cap:
$576.8M
Revenue:
$0
EPS:
$-1.14

How Much Does Larimar Therapeutics Make?

Data Unavailable

Is Larimar Therapeutics Growing As A Company?

Data Unavailable

Larimar Therapeutics Stock Price Performance

What Is Larimar Therapeutics 52-Week High & Low?

Larimar Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Larimar Therapeutics?

Is Larimar Therapeutics Cash Flow Positive?

  • What Is LRMR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.3M
  • What Is Larimar Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $161.8M
  • What Is Larimar Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$107.2M

Larimar Therapeutics Return On Invested Capital

Data Unavailable

Larimar Therapeutics Earnings Date & Stock Price

Larimar Therapeutics Competitors

Larimar Therapeutics Dividend Yield

Larimar Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 35.2%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.74
Upside from Last Price: 161.02%

Major Shareholders

  • How many LRMR shares are owned by institutional investors?
    103M LRMR shares are owned by institutional investors
  • How many LRMR shares are owned by insiders?
    1.1M LRMR shares are owned by insiders